1. Home
  2. RYM vs ZTEK Comparison

RYM vs ZTEK Comparison

Compare RYM & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RYM

RYTHM Inc.

N/A

Current Price

$24.72

Market Cap

60.2M

ML Signal

N/A

Logo Zentek Ltd.

ZTEK

Zentek Ltd.

HOLD

Current Price

$0.57

Market Cap

68.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYM
ZTEK
Founded
2016
2008
Country
United States
Canada
Employees
141
N/A
Industry
Farming/Seeds/Milling
Major Chemicals
Sector
Consumer Staples
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
60.2M
68.8M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
RYM
ZTEK
Price
$24.72
$0.57
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
6.5K
188.8K
Earning Date
05-12-2026
02-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.00
$0.40
52 Week High
$53.65
$1.55

Technical Indicators

Market Signals
Indicator
RYM
ZTEK
Relative Strength Index (RSI) 43.87 43.91
Support Level $24.33 $0.43
Resistance Level $30.35 $0.75
Average True Range (ATR) 1.51 0.08
MACD -0.41 -0.03
Stochastic Oscillator 9.93 3.38

Price Performance

Historical Comparison
RYM
ZTEK

About RYM RYTHM Inc.

Rythm Inc is a USA Based company. The company's portfolio of brands delivers well-being to millions of Americans every year. The company features some of the recognized and trusted names in the cannabis and hemp industries, including RYTHM, incredibles, Dogwalkers, Beboe, Senorita THC Margaritas, &Shine, Doctor Solomon's and Good Green in thousands of physical locations and online channels. With products rooted in quality, safety, and innovation, the Company is shaping cannabis experiences that enhance daily life.

About ZTEK Zentek Ltd.

Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.

Share on Social Networks: